ABSTRACT

Compliance with therapy tends to be very good in the majority of these patients. Surgical therapy is similar to that for patients with moderate obstructive sleep

apnea syndrome (OSAS). However, most patients with severe sleep apnea are obese

and UPPP with tonsillectomy often fails to correct the diffuse airway narrowing

caused by fat deposition in and around the airway musculature. UPPP (with tonsil-

lectomy) might be offered to those CPAP-intolerant patients who are not obese and

have relatively isolated airway narrowing in the retropalatal and oropharyngeal

region. UPPP (with tonsillectomy) in combination with nasal surgery and a combi-

nation of retro-lingual airway enlarging procedures may also be considered for

patients who cannot tolerate CPAP or BiPAP in a manner similar to that described

for moderate OSAS patients. In addition to the retro-lingual airway soft tissue procedures listed, mandibular

and maxillary advancement is a reasonable treatment option for these patients,

either alone if there are demonstrable abnormalities of the facial skeleton or follow-

ing failure of the various soft tissue procedures. In patients with moderate or severe

sleep apnea, studies have demonstrated efficacy that is equivalent to that of CPAP

(23). Tongue reduction procedures (20,21) may also be considered in selected

patients. Surgical reduction of the tongue, however, generally requires a temporary

tracheostomy in the perioperative period, a possible deterrent for some patients. Morbidly obese patients may be candidates for bariatric surgery (24). Bariatric

surgery has also been shown to be beneficial for sleep apnea; however, due to the

long time required for weight loss, these patients should continue on their CPAP

machine until a follow-up sleep study demonstrates resolution of sleep apnea. If

these patients are not compliant with CPAP, then other airway enlarging procedures

may be contemplated in addition to the bariatric surgery. Tracheostomy is the historical gold standard treatment with an 100% success

rate and should be considered for patients intolerant to, noncompliant with, or

unsuccessful with CPAP (25,26).